ADC
1 clinical trial
3 abstracts
1 indication
Indication
Breast CancerAbstract
LOOP: An observational, prospective, multicenter study of patients with non-small cell lung cancer in the US receiving standard-of-care and initiating an approved therapy with risk of pneumonitis/ILD.Org: Waltham, MA,
Clinical trial
A Multicenter, Real-world Study of the Efficacy and Safety of Antibody-drug Conjugates (ADCs) Rechallenge in Patients With Prior Exposure to ADCs Metastatic Breast CancerStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Abstract
Tolerability and toxicity profiles of antibody-drug conjugates for the treatment of malignant neoplasms: A meta-analysis of randomized clinical trials.Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel., Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan,
Abstract
Comparison of lung cancer clinical trials treatment options and standard practice in Brazilian National Health System over the last decade.Org: Sao Paulo State Cancer Institute (ICESP), Instituto do Câncer do Estado de São Paulo (ICESP), University of São Paulo/ICESP,